Cleo Diagnostics Ltd (ASX:COV)
Australia
· Delayed Price · Currency is AUD
0.525
+0.020 (3.96%)
Last updated: Mar 10, 2026, 11:21 AM AEST
Cleo Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
| Other Revenue | 2.56 | 0.85 | 0.21 | - |
| Revenue | 2.56 | 0.85 | 0.21 | - |
| Revenue Growth (YoY) | 1115.45% | 300.91% | - | - |
| Gross Profit | 2.56 | 0.85 | 0.21 | - |
| Selling, General & Admin | 2.48 | 1.88 | 1.1 | 1.37 |
| Research & Development | 3.8 | 2.88 | 2.57 | 0.25 |
| Other Operating Expenses | 0.1 | 0.1 | 0.12 | 0.04 |
| Operating Expenses | 6.44 | 4.93 | 3.85 | 1.7 |
| Operating Income | -3.87 | -4.08 | -3.64 | -1.7 |
| Interest Expense | - | - | -0.03 | -0.11 |
| Interest & Investment Income | 0.24 | 0.34 | 0.39 | - |
| Other Non Operating Income (Expenses) | -0.4 | -0.26 | -0.48 | 0.08 |
| Pretax Income | -4.03 | -4 | -3.76 | -1.73 |
| Net Income | -4.03 | -4 | -3.76 | -1.73 |
| Net Income to Common | -4.03 | -4 | -3.76 | -1.73 |
| Shares Outstanding (Basic) | 129 | 129 | 117 | 26 |
| Shares Outstanding (Diluted) | 129 | 129 | 117 | 26 |
| Shares Change (YoY) | 10.54% | 9.53% | 346.76% | - |
| EPS (Basic) | -0.03 | -0.03 | -0.03 | -0.07 |
| EPS (Diluted) | -0.03 | -0.03 | -0.03 | -0.07 |
| Free Cash Flow | -2.52 | -2.91 | -2.03 | -0.72 |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 |
| Gross Margin | 100.00% | 100.00% | 100.00% | - |
| Operating Margin | -151.15% | -483.01% | -1727.45% | - |
| Profit Margin | -157.36% | -473.17% | -1783.22% | - |
| Free Cash Flow Margin | -98.35% | -344.57% | -964.47% | - |
| EBITDA | -3.81 | -4.02 | -3.58 | -1.66 |
| D&A For EBITDA | 0.06 | 0.06 | 0.06 | 0.04 |
| EBIT | -3.87 | -4.08 | -3.64 | -1.7 |
Source: S&P Capital IQ. Standard template.
Financial Sources.